Envision this possible future clinical scenario: a breast cancer patient and her physicians are deciding on the best possible ...

If your cancer is also hormone receptor-positive, meaning that it needs the ... What is the life expectancy of a HER2-positive breast cancer patient? Life expectancy varies based on the cancer ...

One key piece of information contained in the pathology ... To summarize, being HER2-positive can mean more treatment options, even though your cancer is aggressive. Yet just because your breast ...

Very few patients had to stop treatment due to side effects. The results of the study show variable effects across different tumor types. However, patients with HER2-positive metastatic bile duct ...

Patients with HER2-positive breast cancer that has started ... to be able to control the disease for several years." More information: Presentation: Updated overall survival (OS) outcomes from ...

A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't ...

Prior to DESTINY-Breast06, the randomized phase 3 DESTINY-Breast04 trial showed trastuzumab deruxtecan prolonged PFS and OS in patients with HER2-low unresectable and/or metastatic breast cancer ...

A combination of Enhertu and Perjeta nearly doubled progression-free survival compared to standard therapy in data presented ...

I remember the arguments and the differing opinions about what to do with those who were HER2-positive and lymph ... Miller: Do we have any information on which patients are at greater risk ...

5,6 This test is for patients who have recently been diagnosed with node-negative or node-positive HR+ and HER2- invasive breast ... respond to treatment. This information is different from ...

The Phase 1 clinical trial, currently taking place in Australia, is designed to evaluate the safety, tolerability, and preliminary efficacy of AP402 in HER2+ patients with advanced solid tumors ...